18F-FDG PET-CT结合机器学习聚类揭示肌萎缩侧索硬化症不同代谢表型
该前瞻性研究纳入127例ALS患者和128例健康对照,采用脑18F-FDG PET-CT代谢成像结合K-means共识聚类分析,识别出代谢减弱型与代谢非减弱型两种表型。代谢减弱型患者生存更差(p=0.022)、躯体功能更差(p=0.005)、抑郁更重(p=0.026)且焦虑水平更高(p=0.05)。全外显子测序及影像-转录组分析发现各表型对应特定基因突变和分子通路。
要点
- 脑18F-FDG PET-CT代谢聚类可将ALS分为代谢减弱型与非减弱型两种表型。
- 代谢减弱型与更差生存、更差躯体功能及更重抑郁焦虑相关。
- 无监督机器学习用于PET成像或可有效分类ALS代谢亚型。
核心结论
- 基于脑18F-FDG PET-CT代谢成像的无监督机器学习聚类可识别两种临床病理特征不同的ALS代谢表型。
研究设计与样本
- 前瞻性纳入127例ALS患者和128例健康对照,均行脑18F-FDG PET-CT代谢成像、心理问卷和功能筛查,并采用K-means共识聚类定义神经影像表型。
- 研究进行生存分析,并利用全外显子测序检测ALS相关基因突变,随后开展GO/KEGG通路富集及基于脑代谢活动的影像-转录组分析。
主要发现
- 共识聚类根据葡萄糖代谢活动模式识别出代谢减弱型和代谢非减弱型两种代谢表型。
- 代谢减弱型与更差生存相关(p = 0.022)。
- 代谢减弱型与更差躯体功能相关(p = 0.005)。
- 代谢减弱型与更严重抑郁(p = 0.026)和更高焦虑水平(p = 0.05)相关。
- 全外显子测序和神经影像-转录组分析识别出与各表型相关的特定基因突变和分子通路。
关键数值与推荐
- 研究采用K-means共识聚类分析定义神经影像学表型。
- 代谢减弱型较非减弱型生存更差(p = 0.022)、躯体功能更差(p = 0.005)、抑郁更重(p = 0.026)、焦虑水平更高(p = 0.05)。
临床怎么用
- 脑18F-FDG PET-CT代谢成像结合无监督机器学习聚类有助于对ALS患者进行代谢亚型分类。
- 代谢表型分型或可辅助识别生存更差、功能更差及情绪障碍更重的ALS患者,为个体化治疗策略提供参考。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disorder characterized by significant clinicopathologic heterogeneity. This study aimed to identify distinct ALS phenotypes by integrating brain 18 F-fluorodeoxyglucose positron emission tomography-computed tomography (18 F-FDG PET-CT) metabolic imaging with consensus clustering data. METHODS: This study prospectively enrolled 127 patients with ALS and 128 healthy controls. All participants underwent a brain 18 F-FDG-PET-CT metabolic imaging, psychological questionnaires, and functional screening. K-means consensus clustering was applied to define neuroimaging-based phenotypes. Survival analyses were also performed. Whole exome sequencing (WES) was utilized to detect ALS-related genetic mutations, followed by GO/KEGG pathway enrichment and imaging-transcriptome analysis based on the brain metabolic activity on the 18 F-FDG-PET-CT imaging. RESULTS: Consensus clustering identified two metabolic phenotypes, i.e., the metabolic attenuation phenotype and the metabolic non-attenuation phenotype according to their glucose metabolic activity pattern. The metabolic attenuation phenotype was associated with worse survival (p = 0.022), poorer physical function (p = 0.005), more severe depression (p = 0.026) and greater anxiety level (p = 0.05). WES testing and neuroimaging-transcriptome analysis identified specific gene mutations and molecular pathways with each phenotype. CONCLUSIONS: We identified two distinct ALS phenotypes with varying clinicopathologic features, indicating that the unsupervised machine learning applied to PET imaging may effectively classify metabolic subtypes of ALS. These findings contributed novel insights into the heterogeneous pathophysiology of ALS, which should inform personalized therapeutic strategies for patients with ALS.
引用
- Zhang J, Han F, Wang X, et al. Brain metabolic imaging with 18 F-PET-CT and machine-learning clustering analysis reveal divergent metabolic phenotypes in patients with amyotrophic lateral sclerosis. Eur J Nucl Med Mol Imaging. 2025. PMID: 41042334. doi:10.1007/s00259-025-07585-5
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。